Patent: 9,592,211
✉ Email this page to a colleague
Summary for Patent: 9,592,211
| Title: | Compositions for improvement of brain function |
| Abstract: | A composition comprising alpha-ketoglutaric acid or a pharmaceutically acceptable salt thereof (AKG), and one or more enzymes selected from a group consisting of a lipase, a protease and an amylase, and medical uses thereof in, neurological and/or neurodegenerative disease, neurological trauma, depression or chronic fatigue syndrome. |
| Inventor(s): | Pierzynowski; Stefan (Trelleborg, SE) |
| Assignee: | |
| Application Number: | 14/428,841 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,592,211
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | COTAZYM | pancrelipase | Capsule, Delayed Release | 020580 | 12/09/1996 | ⤷ Try a Trial | 2032-09-19 |
| Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | 04/30/2009 | ⤷ Try a Trial | 2032-09-19 |
| Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | 06/10/2011 | ⤷ Try a Trial | 2032-09-19 |
| Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | 03/14/2013 | ⤷ Try a Trial | 2032-09-19 |
| Digestive Care, Inc. | PERTZYE | pancrelipase | Capsule, Delayed Release | 022175 | 05/17/2012 | ⤷ Try a Trial | 2032-09-19 |
| Digestive Care, Inc. | PERTZYE | pancrelipase | Capsule, Delayed Release | 022175 | 10/06/2016 | ⤷ Try a Trial | 2032-09-19 |
| Digestive Care, Inc. | PERTZYE | pancrelipase | Capsule, Delayed Release | 022175 | 07/13/2017 | ⤷ Try a Trial | 2032-09-19 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
